LONGMONT, Colo.--(BUSINESS WIRE)--Chemizon, the drug discovery division of Optomagic Co. Ltd. announced today the addition of three new members to its senior management team. Dr. Xin Bu, M.D. has been named Director of Biology and Dr. Haihong Ni has been named Director of Computational Chemistry. Both Dr. Bu and Dr. Ni will be based in Chemizon’s Beijing R&D facility and will be tasked with building and managing their respective groups. In addition, Dr. Albert Gyorkos has been named Director of Strategic Planning and will be based in Chemizon’s U.S. offices in Longmont, Co.
